Enliven Therapeutics remains overvalued relative to its early-stage pipeline progress and current financials. ELVN-001 shows promising safety and efficacy signals in heavily pretreated CML patients, with a pivotal phase 3 trial planned for 2026. ELVN is well-capitalized, with over four years of cash runway, but faces a competitive and relatively small CML market.

Toast, Inc. (TOST) is upgraded to Strong Buy as its competitive moat widens and growth prospects remain robust. Toast can benefit from the struggles at key competitor Clover, winning more SMB restaurant deals, and deepening strategic partnerships like the recent Uber integration. Management sees clear paths to doubling US market share, is expanding internationally, and entering new verticals, supporting sustained 20%+ revenue growth.

YieldMax MSTR Option Income Strategy ETF (MSTY) offers high income via covered calls on volatile MSTR, but has suffered alongside MSTR's decline. MSTY's recent price drop is tied to MSTR's weakness and market volatility, not just NAV erosion, with distributions still attractive for income seekers. MSTY is best used as a small, aggressive allocation within a diversified income portfolio, not as a core holding due to its risk profile.

President Donald Trump asked McDonald's for more tartar sauce on Filet-O-Fish during D.C. summit and joked about being first former fry cook to be president.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of KBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

Fortis Inc. (FTS:CA) unveils a $28.8B, 5-year capital plan targeting 7% annualized rate base growth and continued low-risk project execution. FTS maintains its 52-year dividend growth streak, announcing a 4% increase and targeting 4-6% annual dividend growth through 2030. Recent results highlight stable earnings, strong U.S. operations, and a resilient regulatory profile, supporting Fortis' premium valuation among peers.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RICK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.

T1 Energy Inc. ( TE ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Jeffrey Spittel - Executive VP of Investor Relations & Corporate Development Daniel Barcelo - CEO & Chairman Otto Erster Bergesen Evan Calio - Chief Financial Officer Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Gregory Lewis - BTIG, LLC, Research Division Sean Milligan - Needham & Company, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the T1 Energy Third Quarter 2025 Earnings Conference Call.

Vistagen Therapeutics' intranasal pherine drugs target nose-to-brain circuits. This taps into neuropsychiatric, women's health, and oncology indications. Their lead asset is Fasedienol, which is in Phase 3 for SAD. Its PALISADE-3 data may enable a possible NDA submission during 2026. The rest of VTGN's pipeline includes Itruvone, PH80, and PH284. However, I believe VTGN's tight runway will force them to prioritize Fasedienol's R&D.

Iren Limited (IREN) is a rapidly growing dual data center business with a unique blend of Bitcoin mining and AI/HPC hosting operations. IREN's vertical integration, secured 2.9GW power capacity, and strong financing position it well for future growth, despite recent share price volatility. Valuation suggests significant upside potential if execution matches guidance, with a forward P/S ratio becoming attractive by 2027.

NEW YORK--(BUSINESS WIRE)--PVH Corp. Announces CFO Transition.

Cleveland Hopkins International Airport upgrades to improve critical infrastructure DALLAS , Nov. 18, 2025 /PRNewswire/ -- Jacobs (NYSE: J) has been selected to lead program and construction management services for phase one of a $1.6 billion modernization of Cleveland Hopkins International Airport (CLE). The transformative program, CLEvolution, is designed to reimagine the airport experience for millions of travelers by modernizing aging infrastructure enhancing accessibility and passenger flow at Ohio's most traveled airport.

Expects Registration Statement to be Effective by Expiration Date MIAMI , Nov. 18, 2025 /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B) ("Lennar") confirmed today that in view of the reopening of the U.S. federal government, Lennar is proceeding as previously announced with the offer to exchange the approximately 20% of the total outstanding shares of Millrose Properties, Inc. (NYSE: MRP) ("Millrose") it owns for outstanding shares of Lennar Class A common stock (the "Exchange Offer"). The Exchange Offer is scheduled to expire at 12:00 midnight, New York City time, on November 21, 2025 (the "Expiration Date").

Kikoff's One Million-Plus Members will be Equipped to Achieve their Personalized Credit Score Goals and Advance their Financial Health ATLANTA and SAN FRANCISCO , Nov. 18, 2025 /PRNewswire/ -- Equifax ® (NYSE: EFX) and Kikoff , a personal finance platform that expands access to credit and financial services, today announced that Optimal Path ™, the interactive score planner introduced by Equifax earlier this year, will be integrated into the Kikoff platform and rolled out to Kikoff's community of over one million customers. Leveraging the power of The Equifax Cloud ™ and patented EFX.AI capabilities, Optimal Path will integrate with each …

Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Silver slips near key support as gold weakens and Fed rate-cut odds fall, with traders watching major U.S. data for clues on sentiment and short-term direction.

The Goldman Sachs Conviction List is a curated list of stocks that the firm's research team believes have a high likelihood of outperforming the market.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.